{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:52:59Z","timestamp":1781632379100,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:00:00Z","timestamp":1769212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Postoperative recurrence of esophageal cancer is generally associated with poor survival; however, oligo-recurrence, a limited pattern of recurrence, may influence long-term survival outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed 57 patients who developed postoperative recurrence of thoracic esophageal cancer between April 2016 and March 2024. Oligo-recurrence was defined as recurrence involving three or fewer lesions confined to a single organ. Recurrence patterns, treatment strategies, and post-recurrence survival were evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The cohort included 48 men and 9 women, with a median age at recurrence of 72 years (range: 50\u201384 years). Oligo-recurrence occurred in 23 patients (40.4%); of these, 18 (78.3%) received local treatment (surgery or chemoradiotherapy), and 5 (21.7%) received chemotherapy alone. The 2-year post-recurrence survival rate was significantly higher in the oligo group than in the non-oligo group (50.8% vs. 3.7%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). Within the oligo group, 11 patients who achieved disease control with local treatment had a 2-year survival rate of 80%, compared with 13% in the remaining patients (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). Univariate analysis identified early recurrence within 1 year (hazard ratio [HR]: 1.94; 95% confidence interval [CI]: 1.014\u20133.811;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05), oligo-recurrence (HR: 0.28; 95% CI: 0.143\u20130.555;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05), and local treatment (HR: 0.23; 95% CI: 0.107\u20130.525;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05) as significant factors. In multivariate analysis, only local treatment remained independently associated with improved survival (HR: 0.31; 95% CI: 0.087\u20130.998;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.048).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Local treatment for oligo-recurrence is associated with improved survival outcomes in selected patients with recurrent esophageal cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12957-026-04212-x","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T08:16:14Z","timestamp":1769242574000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Survival benefit of local treatment for oligo-recurrence after esophageal cancer surgery"],"prefix":"10.1186","volume":"24","author":[{"given":"Katsushi","family":"Takebayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiko","family":"Kaida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiko","family":"Otake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asuka","family":"Fukuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatsugu","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichiro","family":"Tani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Maehira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruki","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhito","family":"Nitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaji","family":"Tani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,24]]},"reference":[{"issue":"12","key":"4212_CR1","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1245\/s10434-011-1747-7","volume":"18","author":"H Miyata","year":"2011","unstructured":"Miyata H, Yamasaki M, Kurokawa Y, Takiguchi S, Nakajima K, Fujiwara Y, Konishi K, Mori M, Doki Y. Survival factors in patients with recurrence after curative resection of esophageal squamous cell carcinomas. Ann Surg Oncol. 2011;18(12):3353\u201361.","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"4212_CR2","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1002\/cncr.11228","volume":"97","author":"C Mariette","year":"2003","unstructured":"Mariette C, Balon JM, Piessen G, Fabre S, Van Seuningen I, Triboulet JP. Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease. Cancer. 2003;97(7):1616\u201323.","journal-title":"Cancer"},{"issue":"5","key":"4212_CR3","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.21037\/jtd.2018.05.17","volume":"10","author":"F Kato","year":"2018","unstructured":"Kato F, Monma S, Koyanagi K, Kanamori J, Daiko H, Igaki H, Tachimori Y. Long-term outcome after resection for recurrent oesophageal cancer. J Thorac Dis. 2018;10(5):2691\u20139.","journal-title":"J Thorac Dis"},{"issue":"1","key":"4212_CR4","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1245\/s10434-011-2049-9","volume":"19","author":"N Ando","year":"2012","unstructured":"Ando N, Kato H, Igaki H, Shinoda M, Ozawa S, Shimizu H, Nakamura T, Yabusaki H, Aoyama N, Kurita A, Ikeda K, Kanda T, Tsujinaka T, Nakamura K, Fukuda H. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2012;19(1):68\u201374.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"4212_CR5","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s10388-023-00993-2","volume":"20","author":"Y Kitagawa","year":"2023","unstructured":"Kitagawa Y, Ishihara R, Ishikawa H, Ito Y, Oyama T, Oyama T, Kato K, Kato H, Kawakubo H, Kawachi H, Kuribayashi S, Kono K, Kojima T, Takeuchi H, Tsushima T, Toh Y, Nemoto K, Booka E, Makino T, Matsuda S, Matsubara H, Mano M, Minashi K, Miyazaki T, Muto M, Yamaji T, Yamatsuji T, Yoshida M. Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 1. Esophagus. 2023;20(3):343\u201372.","journal-title":"Esophagus"},{"issue":"3","key":"4212_CR6","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s10388-023-00994-1","volume":"20","author":"Y Kitagawa","year":"2023","unstructured":"Kitagawa Y, Ishihara R, Ishikawa H, Ito Y, Oyama T, Oyama T, Kato K, Kato H, Kawakubo H, Kawachi H, Kuribayashi S, Kono K, Kojima T, Takeuchi H, Tsushima T, Toh Y, Nemoto K, Booka E, Makino T, Matsuda S, Matsubara H, Mano M, Minashi K, Miyazaki T, Muto M, Yamaji T, Yamatsuji T, Yoshida M. Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 2. Esophagus. 2023;20(3):373\u201389.","journal-title":"Esophagus"},{"issue":"7","key":"4212_CR7","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1093\/jjco\/hyt061","volume":"43","author":"K Nakamura","year":"2013","unstructured":"Nakamura K, Kato K, Igaki H, Ito Y, Mizusawa J, Ando N, Udagawa H, Tsubosa Y, Daiko H, Hironaka S, Fukuda H, Kitagawa Y, Japan Esophageal Oncology Group\/Japan Clinical Oncology Group. Three-arm phase III trial comparing cisplatin plus 5-FU (CF) versus docetaxel, cisplatin plus 5-FU (DCF) versus radiotherapy with CF (CF-RT) as preoperative therapy for locally advanced esophageal cancer (JCOG1109, next study). Jpn J Clin Oncol. 2013;43(7):752\u20135.","journal-title":"Jpn J Clin Oncol"},{"issue":"4","key":"4212_CR8","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1056\/NEJMoa2409408","volume":"392","author":"J Hoeppner","year":"2025","unstructured":"Hoeppner J, Brunner T, Schmoor C, Bronsert P, Kulemann B, Claus R, Utzolino S, Izbicki JR, Gockel I, Gerdes B, Ghadimi M, Reichert B, Lock JF, Bruns C, Reitsamer E, Schmeding M, Benedix F, Keck T, Folprecht G, Thuss-Patience P, Neumann UP, Pascher A, Imhof D, Daum S, Strieder T, Krautz C, Zimmermann S, Werner J, Mahlberg R, Illerhaus G, Grimminger P, Lordick F. Perioperative chemotherapy or preoperative chemoradiotherapy in esophageal cancer. N Engl J Med. 2025;392(4):323\u201335.","journal-title":"N Engl J Med"},{"issue":"1","key":"4212_CR9","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s13014-019-1377-y","volume":"14","author":"J Chen","year":"2019","unstructured":"Chen J, Yin W, Yao H, Gu W. Salvage treatment for lymph node recurrence after radical resection of esophageal squamous cell carcinoma. Radiat Oncol. 2019;14(1):169.","journal-title":"Radiat Oncol"},{"issue":"1","key":"4212_CR10","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1442-2050.2011.01215.x","volume":"25","author":"M Watanabe","year":"2012","unstructured":"Watanabe M, Nishida K, Kimura Y, Miyazaki M, Baba H. Salvage lymphadenectomy for cervical lymph node recurrence after esophagectomy for squamous cell carcinoma of the thoracic esophagus. Dis Esophagus. 2012;25(1):62\u20136.","journal-title":"Dis Esophagus"},{"issue":"9","key":"4212_CR11","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1245\/s10434-008-0016-x","volume":"15","author":"T Nakamura","year":"2008","unstructured":"Nakamura T, Ota M, Narumiya K, Sato T, Ohki T, Yamamoto M, Mitsuhashi N. Multimodal treatment for lymph node recurrence of esophageal carcinoma after curative resection. Ann Surg Oncol. 2008;15(9):2451\u20137.","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"4212_CR12","doi-asserted-by":"publisher","first-page":"238","DOI":"10.21037\/atm.2019.04.64","volume":"7","author":"Z Wang","year":"2019","unstructured":"Wang Z, Lin S, Wang F, Liu S. Salvage lymphadenectomy for isolated cervical lymph node recurrence after curative resection of thoracic esophageal squamous cell carcinoma. Ann Transl Med. 2019;7(11):238.","journal-title":"Ann Transl Med"},{"issue":"2","key":"4212_CR13","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1245\/s10434-014-4008-8","volume":"22","author":"X Ma","year":"2015","unstructured":"Ma X, Zhao K, Guo W, Yang S, Zhu X, Xiang J, Zhang Y, Li H. Salvage lymphadenectomy versus salvage radiotherapy\/chemoradiotherapy for recurrence in cervical lymph node after curative resection of esophageal squamous cell carcinoma. Ann Surg Oncol. 2015;22(2):624\u20139.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"4212_CR14","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1007\/s00268-018-04904-w","volume":"43","author":"A Shimada","year":"2019","unstructured":"Shimada A, Tsushima T, Tsubosa Y, Booka E, Takebayashi K, Niihara M, Isaka M, Ohde Y, Machida N, Onozawa Y, Yasui H, Takeuchi H, Kitagawa Y. Validity of surgical resection for lymph node or pulmonary recurrence of esophageal cancer after definitive treatment. World J Surg. 2019;43(5):1286\u201393.","journal-title":"World J Surg"},{"issue":"1","key":"4212_CR15","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s12885-019-5549-9","volume":"19","author":"W Koizumi","year":"2019","unstructured":"Koizumi W, Kitago M, Shinoda M, Yagi H, Abe Y, Oshima G, Hori S, Inomata K, Kawakubo H, Kawaida M, Kitagawa Y. Successful resection of pancreatic metastasis from oesophageal squamous cell carcinoma: a case report and review of the literature. BMC Cancer. 2019;19(1):320.","journal-title":"BMC Cancer"},{"issue":"1","key":"4212_CR16","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1245\/s10434-014-3970-5","volume":"22","author":"Y Hiyoshi","year":"2015","unstructured":"Hiyoshi Y, Morita M, Kawano H, Otsu H, Ando K, Ito S, Miyamoto Y, Sakamoto Y, Saeki H, Oki E, Ikeda T, Baba H, Maehara Y. Clinical significance of surgical resection for the recurrence of esophageal cancer after radical esophagectomy. Ann Surg Oncol. 2015;22(1):240\u20136.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"4212_CR17","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s00268-012-1830-7","volume":"37","author":"H Ichida","year":"2013","unstructured":"Ichida H, Imamura H, Yoshimoto J, Sugo H, Kajiyama Y, Tsurumaru M, Suzuki K, Ishizaki Y, Kawasaki S. Pattern of postoperative recurrence and hepatic and\/or pulmonary resection for liver and\/or lung metastases from esophageal carcinoma. World J Surg. 2013;37(2):398\u2013407.","journal-title":"World J Surg"},{"key":"4212_CR18","volume-title":"Japanese classification of esophageal cancer 2nd. English ed","author":"Japanese Research Society for esophageal diseases","year":"2008","unstructured":"Japanese Research Society for esophageal diseases. Japanese classification of esophageal cancer 2nd. English ed. Tokyo: Kanehara; 2008."},{"issue":"9","key":"4212_CR19","first-page":"1001","volume":"85","author":"T Onodera","year":"1984","unstructured":"Onodera T, Goseki N, Kosaki G. Prognostic nutritional index in Gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi. 1984;85(9):1001\u20135.","journal-title":"Nihon Geka Gakkai Zasshi"},{"issue":"1","key":"4212_CR20","first-page":"38","volume":"20","author":"J Ignacio de Ul\u00edbarri","year":"2005","unstructured":"Ignacio de Ul\u00edbarri J, Gonz\u00e1lez-Madro\u00f1o A, de Villar NG, Gonz\u00e1lez P, Gonz\u00e1lez B, Mancha A, Rodr\u00edguez F, Fern\u00e1ndez G. CONUT: A tool for controlling nutritional status. First validation in a hospital population. Nutr Hosp. 2005;20(1):38\u201345.","journal-title":"Nutr Hosp"},{"issue":"4","key":"4212_CR21","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.21873\/anticanres.14164","volume":"40","author":"T Yamamoto","year":"2020","unstructured":"Yamamoto T, Niibe Y, Matsumoto Y, Dekura Y, Oh RJ, Yamashita H, Kakuhara H, Aoki M, Jingu K. Stereotactic body radiotherapy for pulmonary oligometastases from esophageal cancer: results and prognostic factors. Anticancer Res. 2020;40(4):2065\u201372.","journal-title":"Anticancer Res"},{"issue":"6","key":"4212_CR22","doi-asserted-by":"publisher","first-page":"403","DOI":"10.5090\/jcs.23.050","volume":"56","author":"M Kang","year":"2023","unstructured":"Kang M, Kim W, Kang CH, Na KJ, Park S, Lee HJ, Park IK, Kim YT. The prognostic value of oligo-recurrence following esophagectomy for esophageal cancer. J Chest Surg. 2023;56(6):403\u201311.","journal-title":"J Chest Surg"},{"issue":"3","key":"4212_CR23","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transpl. 2013;48(3):452\u20138.","journal-title":"Bone Marrow Transpl"},{"issue":"1","key":"4212_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10388-021-00878-2","volume":"19","author":"K Kudou","year":"2022","unstructured":"Kudou K, Saeki H, Nakashima Y, Kimura Y, Oki E, Mori M, Shimokawa M, Kakeji Y, Toh Y, Doki Y, Matsubara H. Clinical outcomes of surgical resection for recurrent lesion after curative esophagectomy for esophageal squamous cell carcinoma: a nationwide, large-scale retrospective study. Esophagus. 2022;19(1):57\u201368.","journal-title":"Esophagus"},{"issue":"3","key":"4212_CR25","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1245\/s10434-019-08175-0","volume":"27","author":"Y Ohkura","year":"2020","unstructured":"Ohkura Y, Shindoh J, Ueno M, Iizuka T, Udagawa H. Clinicopathologic characteristics of oligometastases from esophageal cancer and long-term outcomes of resection. Ann Surg Oncol. 2020;27(3):651\u20139.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"4212_CR26","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.21873\/anticanres.14208","volume":"40","author":"CY Lin","year":"2020","unstructured":"Lin CY, Fang HY, Lein MY, Lin CC, Bai LY, Tsai MH, Chen CC, Hsieh TC, Wang YC, Liang JA, Li CC, Chien CR. Clinical outcomes and prognostic factors of patients with esophageal squamous cell carcinoma with oligo-recurrence treated with radical re-irradiation. Anticancer Res. 2020;40(5):2387\u201392.","journal-title":"Anticancer Res"},{"issue":"2","key":"4212_CR27","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","volume":"250","author":"PA Clavien","year":"2009","unstructured":"Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santiba\u00f1es E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187\u201396.","journal-title":"Ann Surg"},{"issue":"2","key":"4212_CR28","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205\u201313.","journal-title":"Ann Surg"},{"issue":"4","key":"4212_CR29","doi-asserted-by":"publisher","first-page":"704","DOI":"10.3390\/cancers16040704","volume":"16","author":"Y Sato","year":"2024","unstructured":"Sato Y, Tanaka Y, Yokoi R, Tsuchiya H, Sengoku Y, Fukada M, Yasufuku I, Asai R, Tajima JY, Kiyama S, Kato T, Murase K, Matsuhashi N. Oligometastases of esophageal squamous cell carcinoma: a review. Cancers (Basel). 2024;16(4):704.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"4212_CR30","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1186\/s12885-022-09739-2","volume":"22","author":"PC Tsai","year":"2022","unstructured":"Tsai PC, Chien HC, Hsu PK, Hung JJ, Huang CS, Hsu WH, Hsu HS. Post-recurrence survival analysis in patients with oligo-recurrence after curative esophagectomy. BMC Cancer. 2022;22(1):637.","journal-title":"BMC Cancer"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04212-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04212-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04212-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:04:15Z","timestamp":1781629455000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04212-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,24]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4212"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04212-x","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,24]]},"assertion":[{"value":"30 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. This study obtained the approval of the ethics committee in Shiga University of Medical Science (Approval No. registration no. R2019-143).Informed consent was obtained from all patients or their family members on an opt-out basis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"93"}}